ARCHIVES

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

This article is from The Cancer Letter archive.

Vol. 33 No. 08 | March 2, 2007

Download PDF Visit The Full Archive

Related Articles

NEJM Sanctioned For Giving CME Credit For Controversial Lung Screening Paper; ACCME Demanded Corrective Action

January 9, 2009

In Brief: Surgeons Oncology Group Gets NCI Funding To Conduct Multicenter Clinical Trials

April 17, 1998

Endoscopic Surgery Provides Equal Or Better Results

September 30, 2005

New Tests Rule Out Theory On Polio Vaccine-AIDS Link.

October 6, 2000

NCI Contract Awards

November 1, 1996

HPV Vaccine Cervarix Active In 100% Of Women In Study

July 27, 2007